Understanding monogenic Parkinson’s disease at a global scale

Johanna Junker, Lara M. Lange, Eva-Juliane Vollstedt, Karisha Roopnarain, Maria Leila M. Doquenia, Azlina Ahmad Annuar, Micol Avenali, Soraya Bardien, Natascha Bahr, Melina Ellis, Caterina Galandra, Thomas Gasser, Peter Heutink, Anastasia Illarionova, Yuliia Kanana, Ignacio J. Keller Sarmiento, Kishore R. Kumar, Shen-Yang Lim, Harutyun Madoev, Ignacio F. Mata, Niccolò E. Mencacci, Mike A. Nalls, Shalini Padmanabhan, Cholpon Shambetova, J Solle, Ai-Huey Tan, Joanne Trinh, Enza Maria Valente, Andrew Singleton, Cornelis Blauwendraat, Katja Lohmann, Zih-Hua Fang, Christine Klein, the Global Parkinson’s Genetics Program (GP2)
doi: https://doi.org/10.1101/2024.03.12.24304154

Article Information

doi 
https://doi.org/10.1101/2024.03.12.24304154
History 
  • April 9, 2024.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Johanna Junker, MD*,1,2,
  2. Lara M. Lange, MD*,1,2,
  3. Eva-Juliane Vollstedt, MD1,
  4. Karisha Roopnarain, MD3,
  5. Maria Leila M. Doquenia, MD1,
  6. Azlina Ahmad Annuar, PhD4,
  7. Micol Avenali, MD5,6,
  8. Soraya Bardien, PhD7,8,
  9. Natascha Bahr1,
  10. Melina Ellis, BSc9,10,
  11. Caterina Galandra, MD5,11,
  12. Thomas Gasser, MD, FANA, FEAN12,13,
  13. Peter Heutink, PhD12,13,
  14. Anastasia Illarionova, PhD13,
  15. Yuliia Kanana, PhD1,
  16. Ignacio J. Keller Sarmiento, MD14,
  17. Kishore R. Kumar, MBBS, PhD, FRACP10,15,16,
  18. Shen-Yang Lim, MD, FRACP17,
  19. Harutyun Madoev, MS1,
  20. Ignacio F. Mata, PhD18,
  21. Niccolò E. Mencacci, MD, PhD14,
  22. Mike A. Nalls, PhD19,20,
  23. Shalini Padmanabhan, PhD21,
  24. Cholpon Shambetova, MD1,
  25. J Solle, MBA22,
  26. Ai-Huey Tan, MD, PhD, FRCP17,
  27. Joanne Trinh, PhD1,
  28. Enza Maria Valente, MD6,11,
  29. Andrew Singleton, PhD20,23,
  30. Cornelis Blauwendraat, PhD20,
  31. Katja Lohmann, PhD1,
  32. Zih-Hua Fang, PhD13,
  33. Christine Klein, MD1,†,
  34. the Global Parkinson’s Genetics Program (GP2)
  1. 1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
  2. 2Department of Neurology, University Clinic Schleswig-Holstein, Luebeck, Germany
  3. 3Department of Neurology, University of Free State, Bloemfontein, South Africa
  4. 4Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  5. 5Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
  6. 6IRCCS Mondino Foundation, Pavia, Italy
  7. 7Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
  8. 8South African Medical Research Council, Genomics of Brain Disorders Research Unit, Stellenbosch University, Cape Town, South Africa
  9. 9Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord, New South Wales, Australia
  10. 10Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
  11. 11Department of Molecular Medicine, University of Pavia, Pavia, Italy
  12. 12Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
  13. 13German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
  14. 14Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA
  15. 15Translational Neurogenomics, Genomic and Inherited Disease Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
  16. 16Molecular Medicine Laboratory and Neurology Department, Concord Repatriation General Hospital, The University of Sydney, Concord, New South Wales, Australia
  17. 17Division of Neurology, Department of Medicine, and the Mah Pooi Soo and Tan Chin Nam Centre for Parkinson’s and Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  18. 18Genomic Medicine Institute (GMI), Cleveland Clinic, Cleveland, OH, United States
  19. 19DataTecnica, Washington DC, USA
  20. 20Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
  21. 21Discovery & Translational Research, The Michael J. Fox Foundation for Parkinson’s Research, New York, New York, USA
  22. 22Department of Clinical Research, Michael J. Fox Foundation for Parkinson’s Research, New York City, NY, USA
  23. 23Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, Bethesda, MD, USA
  1. ↵†Corresponding Author:
    Christine Klein, MD, Institute of Neurogenetics, University of Lübeck, and University-Hospital Schleswig Holstein, BMF, Building 67, Ratzeburger Allee 160, 23538 Lübeck, Germany, Tel: +49-451-31018200, Email: christine.klein{at}uni-luebeck.de

  1. ↵* These authors have contributed equally to the work

Back to top
Posted April 09, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Understanding monogenic Parkinson’s disease at a global scale
Johanna Junker, Lara M. Lange, Eva-Juliane Vollstedt, Karisha Roopnarain, Maria Leila M. Doquenia, Azlina Ahmad Annuar, Micol Avenali, Soraya Bardien, Natascha Bahr, Melina Ellis, Caterina Galandra, Thomas Gasser, Peter Heutink, Anastasia Illarionova, Yuliia Kanana, Ignacio J. Keller Sarmiento, Kishore R. Kumar, Shen-Yang Lim, Harutyun Madoev, Ignacio F. Mata, Niccolò E. Mencacci, Mike A. Nalls, Shalini Padmanabhan, Cholpon Shambetova, J Solle, Ai-Huey Tan, Joanne Trinh, Enza Maria Valente, Andrew Singleton, Cornelis Blauwendraat, Katja Lohmann, Zih-Hua Fang, Christine Klein, the Global Parkinson’s Genetics Program (GP2)
medRxiv 2024.03.12.24304154; doi: https://doi.org/10.1101/2024.03.12.24304154
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area